This project aims to measure and modulate a mood depressive episode (MDE) in hospitalized patients with borderline personality disorder (BPD) and comorbid mood depressive disorder (MDD) or bipolar disorder II (BAD II) in a current mood depressive episode (MDE). This study will test the antidepressant effect of aiTBS stimulation over the left dorsolateral prefrontal cortex (L-DLPFC), and aiTBS stimulation over the dorsomedial prefrontal cortex (DMPFC) compared with sham.
This study evaluates the antidepressant effects of an accelerated schedule of theta-burst stimulation, termed accelerated intermittent theta-burst stimulation (aiTBS), in hospitalized patients with borderline personality disorder (BPD) and comorbid mood depressive disorder (MDD) or bipolar disorder II (BAD II) in a current mood depressive episode (MDE).